Ping An Healthcare and Technology Company Limited (“PA GOODDOCTOR”) has issued its proxy circular for the annual general meeting (AGM) to be held on 23 April 2026 at 2:00 p.m. in Shanghai.

Key resolutions up for shareholder approval are as follows:

1. Financial Statements • Adoption of the audited consolidated financial statements and directors’ and auditor’s reports for the year ended 31 December 2025.

2. Board Composition and Remuneration • Re-election of five retiring directors: executive directors Mr. Mingke He and Ms. Luoqi Zang; non-executive directors Ms. Xin Fu and Mr. Ziyang Zhu; and independent non-executive director Mr. Yunwei Tang. • Authorisation for the board to determine directors’ remuneration.

3. Auditor • Re-appointment of Ernst & Young as external auditor until the conclusion of the next AGM, with the board authorised to fix its remuneration for the financial year ending 31 December 2026.

4. Capital Management Mandates • General mandate permitting directors to issue, allot and deal with additional shares representing up to 20% of the company’s issued share capital, including any sale or transfer of treasury shares. • Mandate to buy back shares not exceeding 10% of issued share capital (excluding any treasury shares). • Extension of the share-issuance mandate by the number of shares repurchased under the buy-back mandate.

Administrative details include a proxy submission deadline of 2:00 p.m. on 21 April 2026 (Hong Kong time) to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. Each shareholder is entitled to one vote per share on a poll and may appoint one or more proxies to attend and vote at the AGM.